Naturhouse Health, S.A.

BME:NTH Stock Report

Market Cap: €104.0m

Naturhouse Health Future Growth

Future criteria checks 2/6

Naturhouse Health is forecast to grow earnings and revenue by 2.3% and 2% per annum respectively. EPS is expected to grow by 1.4% per annum. Return on equity is forecast to be 33.1% in 3 years.

Key information

2.3%

Earnings growth rate

1.4%

EPS growth rate

Specialty Retail earnings growth15.3%
Revenue growth rate2.0%
Future return on equity33.1%
Analyst coverage

Low

Last updated01 Oct 2024

Recent future growth updates

No updates

Recent updates

Some May Be Optimistic About Naturhouse Health's (BME:NTH) Earnings

Oct 07
Some May Be Optimistic About Naturhouse Health's (BME:NTH) Earnings

We Think Naturhouse Health's (BME:NTH) Solid Earnings Are Understated

Mar 23
We Think Naturhouse Health's (BME:NTH) Solid Earnings Are Understated

Calculating The Fair Value Of Naturhouse Health, S.A. (BME:NTH)

Feb 11
Calculating The Fair Value Of Naturhouse Health, S.A. (BME:NTH)

Naturhouse Health (BME:NTH) Has A Pretty Healthy Balance Sheet

Oct 05
Naturhouse Health (BME:NTH) Has A Pretty Healthy Balance Sheet

What Does Naturhouse Health, S.A.'s (BME:NTH) Share Price Indicate?

Sep 22
What Does Naturhouse Health, S.A.'s (BME:NTH) Share Price Indicate?

What Does Naturhouse Health, S.A.'s (BME:NTH) Share Price Indicate?

May 10
What Does Naturhouse Health, S.A.'s (BME:NTH) Share Price Indicate?

Is Naturhouse Health (BME:NTH) A Risky Investment?

Mar 24
Is Naturhouse Health (BME:NTH) A Risky Investment?

Can Mixed Fundamentals Have A Negative Impact on Naturhouse Health, S.A. (BME:NTH) Current Share Price Momentum?

Mar 06
Can Mixed Fundamentals Have A Negative Impact on Naturhouse Health, S.A. (BME:NTH) Current Share Price Momentum?

A Look At The Intrinsic Value Of Naturhouse Health, S.A. (BME:NTH)

Jan 14
A Look At The Intrinsic Value Of Naturhouse Health, S.A. (BME:NTH)

Would Shareholders Who Purchased Naturhouse Health's (BME:NTH) Stock Five Years Be Happy With The Share price Today?

Dec 01
Would Shareholders Who Purchased Naturhouse Health's (BME:NTH) Stock Five Years Be Happy With The Share price Today?

Earnings and Revenue Growth Forecasts

BME:NTH - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026521010141
12/31/202551109141
12/31/2024501010141
6/30/202450101515N/A
3/31/202450111718N/A
12/31/202350112021N/A
9/30/202350111616N/A
6/30/202351101111N/A
3/31/2023511099N/A
12/31/2022521067N/A
9/30/20225411910N/A
6/30/202256121212N/A
3/31/20225813N/AN/AN/A
12/31/202158131616N/A
9/30/20215713N/AN/AN/A
6/30/202159142121N/A
3/31/20215310N/AN/AN/A
12/31/20205591415N/A
9/30/2020609N/AN/AN/A
6/30/2020649910N/A
3/31/20207712N/AN/AN/A
12/31/201982131920N/A
9/30/20198313N/AN/AN/A
6/30/201983131718N/A
3/31/20198515N/AN/AN/A
12/31/201887151920N/A
9/30/20188816N/AN/AN/A
6/30/201891171819N/A
3/31/20189318N/AN/AN/A
12/31/20179520N/A16N/A
9/30/20179621N/AN/AN/A
6/30/20179822N/A15N/A
3/31/20179822N/AN/AN/A
12/31/20169823N/A16N/A
9/30/20169823N/AN/AN/A
6/30/20169823N/A23N/A
3/31/20169623N/AN/AN/A
12/31/20159623N/A21N/A
9/30/20159623N/AN/AN/A
6/30/20159623N/A22N/A
3/31/20159623N/AN/AN/A
12/31/20149623N/A25N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NTH's forecast earnings growth (2.3% per year) is above the savings rate (1.8%).

Earnings vs Market: NTH's earnings (2.3% per year) are forecast to grow slower than the Spanish market (8.2% per year).

High Growth Earnings: NTH's earnings are forecast to grow, but not significantly.

Revenue vs Market: NTH's revenue (2% per year) is forecast to grow slower than the Spanish market (4.9% per year).

High Growth Revenue: NTH's revenue (2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: NTH's Return on Equity is forecast to be high in 3 years time (33.1%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/23 18:36
End of Day Share Price 2025/01/23 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Naturhouse Health, S.A. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Carlos Javier Treviño PeinadorBanco Santander
Fernando Cordero BarreiraBanco Santander
Luis Esteban ArribasLighthouse-IEAF Servicios de Analisis